Clinical Trials Search Results - National Cancer Institute

Clinical Trials Search Results - National Cancer Institute

CANCER TREATMENT

• Types of Treatment
• Side Effects
• Clinical Trials Information for Patients and Caregivers
  • Find NCI-Supported Clinical Trials
    • How to Join a Cancer Clinical Trial
    • Help With Clinical Trials Search
  • What Are Clinical Trials?
  • Paying for Clinical Trials
  • Patient Safety
  • Deciding to Take Part in a Trial
  • Questions to Ask about Treatment Clinical Trials
  • Selected NCI-Supported Trials
• A to Z List of Cancer Drugs
• Complementary & Alternative Medicine (CAM)
• Questions to Ask about Your Treatment
• Research

126.

Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer

Status: Active
Phase: Phase III
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: ANZGOG-0902/GOG-0274/RTOG-1174, NCI-2011-02978, ANZGOG-0902, CDR0000706698, GOG-0274, RTOG-1174, ANZGOG-0902-GOG-0274, NCT01414608

127.

Modifications to Radical Prostatectomy in Improving Outcomes in Patients with Prostate Cancer

Status: Active
Phase: Phase III
Type: Treatment
Age: 21 and over
Trial IDs: 11-096, NCI-2011-02377, NCT01407263

128.

Melphalan with or without Busulfan before Stem Cell Transplant in Treating Patients with Multiple Myeloma

Status: Active
Phase: Phase III
Type: Treatment
Age: 18 to 70
Trial IDs: 2010-0071, NCI-2011-02760, cs2010-0032635MA, NCT01413178

129.

Phase 3 Study of ProstAtak™ Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer

Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: PrTK03, NCI-2012-01912, NCT01436968

130.

Thoracic Epidural or Intravenous Patient Controlled Pain Management in Treating Patients Undergoing Liver or Pancreatic Surgery

Status: Active
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: 2011-0146, NCI-2011-03284, NCT01438476

131.

Standard or Accelerated Hypofractionated Image-Guided Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer and Poor Performance Status

Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: STU 052011-093, NCI-2013-00783, NCT01459497

132.

A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Patients With Relapse or Refractory Multiple Myeloma

Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: AB06002, NCI-2013-00616, NCT01470131

133.

Assessing Compliance with Mercaptopurine Treatment in Younger Patients with Acute Lymphoblastic Leukemia in First Remission

Status: Active
Phase: Phase III
Type: Behavioral study, Biomarker/Laboratory analysis, Educational/Counseling/Training
Age: 12 to 20
Trial IDs: ACCL1033, NCI-2012-00105, CDR0000721559, NCT01476852, COG-ACCL1033, NCT01503632

134.

Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY)

Status: Active
Phase: Phase III
Type: Prevention
Age: 15 and over
Trial IDs: GHRT01, NCI-2014-02097, NCT01479283

135.

Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer

Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: TS-102, NCI-2012-00575, NCT01483027

136.

Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients following Donor Stem Cell Transplant

Status: Active
Phase: Phase III
Type: Supportive care
Age: 3 months to 20 years
Trial IDs: ACCL1131, NCI-2012-00102, CDR0000721415, COG-ACCL1131, NCT01503515

137.

Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients with High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery

Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: GOG-0277, NCI-2012-00249, CDR0000724874, IRCI 001, NCT01533207

138.

Dactinomycin or Methotrexate in Treating Patients with Low-Risk Gestational Trophoblastic Neoplasia

Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: GOG-0275, NCI-2012-00250, CDR0000725211, PGOG-0275_A08PAMDREVW01, NCT01535053

139.

Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Patients with Early-Stage Breast Cancer

Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Age: Postmenopausal
Trial IDs: S1200, NCI-2012-00251, CDR0000725249, SWOG-S1200, NCT01535066

140.

Bioimpedance Spectroscopy in Quantification of Lymphedema in Patients with Breast Cancer

Status: Active
Phase: Phase III
Type: Diagnostic
Age: 18 and over
Trial IDs: 11-325, NCI-2012-00144, NCT01544335

141.

Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer

Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: TS-103, NCI-2012-01029, NCT01556490

142.

The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)

Status: Active
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: AZA-MDS-003, NCI-2013-00382, 2012-002471-34, NCT01566695

143.

Testosterone in Treating Postmenopausal Patients with Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment

Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: A221102, NCI-2012-00719, CDR0000730083, CALGB-A221102, NCCTG-N10C7, NCT01573442

144.

Pazopanib Hydrochloride in Treating Patients with Metastatic Kidney Cancer Who Have No Evidence of Disease after Surgery

Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Tissue collection/Repository, Treatment
Age: 18 and over
Trial IDs: E2810, NCI-2012-00723, CDR0000730383, ECOG-E2810, NCT01575548

145.

Duloxetine Hydrochloride in Treating Muscle, Bone, and Joint Pain in Patients With Early-Stage Breast Cancer Receiving Hormone Therapy

Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Age: Not specified
Trial IDs: S1202, NCI-2012-01960, CDR0000730691, SWOG-S1202, NCT01598298

146.

Stereotactic Radiosurgery or Whole Brain Radiation Therapy in Treating Patients with Newly Diagnosed Non-melanoma Brain Metastases

Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: 2011-0884, NCI-2014-02058, NCI-2012-00850, NCT01592968

147.

Double Cord Versus Haploidentical (BMT CTN 1101)

Status: Active
Phase: Phase III
Type: Treatment
Age: 18 to 70
Trial IDs: BMTCTN1101, NCI-2014-00307, 2U10HL069294-11, 715, NCT01597778

148.

Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma

Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: IELSG37, NCI-2014-01062, NCT01599559

149.

Robotic Assisted Laparoscopic Prostatectomy with or without Pelvic Drain Placement in Reducing Adverse Events after Surgery in Patients with Prostate Cancer

Status: Active
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: 11113, NCI-2012-00558, NCT01613651

150.

Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer

Status: Active
Phase: Phase III
Type: Treatment
Age: 18 to 75
Trial IDs: KGOG 1027/THAI 2012, NCI-2016-01003, NCT01561586